Indications and uses
relieves heartburn associated with acid indigestion and sour stomach prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain foods and beverages
relieves heartburn associated with acid indigestion and sour stomach prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain foods and beverages
adults and children 12 years and over: ▪ to relieve symptoms, swallow 1 tablet with a glass of water ▪ to prevent symptoms, swallow 1 tablet with a glass of water right before or any time up to 30 minutes before eating food or drinking beverages that cause heartburn ▪ do not take more than 2 tablets in 24 hours children under 12 years: ask a doctor
Drug Facts
Cimetidine 200mg
Acid reducer
Allergy alert: Do not use if you are allergic to cimetidine or other acid reducers.
you are taking a prescription drug.
Acid reducers may interact with certain prescription drugs.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
store at 15-30ºC (59-86ºF)
cellulose, corn starch, hypromellose, magnesium stearate, polyethylene glycol, polysorbate 80, povidone, sodium lauryl sulfate, sodium starch glycolate, titanium dioxide
Call toll-free 1-800-482-4394 weekdays
tagamet.com
Tagamet® HB 200
Cimetidine Tablets 200 mg
Acid Reducer
70 tablets (70 doses)
Tagamet® HB 200
Cimetidine Tablets 200 mg
Acid Reducer
30 tablets (30 doses)
Tagamet ® HB 200
Cimetidine Tablets 200 mg
Acid Reducer
6 tablets (6 doses)
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 197505 | cimetidine 200 MG Oral Tablet | PSN | 9 |
| 104062 | Tagamet HB 200 MG Oral Tablet | PSN | 9 |
| 104062 | cimetidine 200 MG Oral Tablet [Tagamet] | SBD | 9 |
| 197505 | cimetidine 200 MG Oral Tablet | SCD | 9 |
| 104062 | Tagamet 200 MG Oral Tablet | SY | 9 |
| 104062 | Tagamet HB 200 MG Oral Tablet | SY | 9 |
| Class | Version | Type | Effective |
|---|---|---|---|
| CIMETIDINE Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 8f48ba86-02a3-4def-9efa-3a8140fd7adf | Product name | 2 | 20250624 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63029-222-01 | Tagamet | 30 in 1 BLISTER PACK | TABLET | 30 | 9 | |
| 63029-222-01 | Tagamet | 1 in 1 BOX | TABLET | 1 | 9 | |
| 63029-222-02 | Tagamet | 6 in 1 BLISTER PACK | TABLET | 6 | 9 | |
| 63029-222-02 | Tagamet | 1 in 1 BOX | TABLET | 1 | 9 | |
| 63029-222-03 | Tagamet | 50 in 1 BLISTER PACK | TABLET | 50 | 9 | |
| 63029-222-03 | Tagamet | 1 in 1 BOX | TABLET | 1 | 9 | |
| 63029-222-04 | Tagamet | 4 in 1 BOX | TABLET | 4 | 9 | |
| 63029-222-04 | Tagamet | 10 in 1 BLISTER PACK | TABLET | 10 | 9 | |
| 63029-222-05 | Tagamet | 4 in 1 BOX | TABLET | 4 | 9 | |
| 63029-222-05 | Tagamet | 9 in 1 BLISTER PACK | TABLET | 9 | 9 | |
| 63029-222-06 | Tagamet | 7 in 1 BOX | TABLET | 7 | 9 | |
| 63029-222-06 | Tagamet | 10 in 1 BLISTER PACK | TABLET | 10 | 9 | |
| 63029-222-09 | Tagamet | 90 in 1 BOTTLE | TABLET | 90 | 9 | |
| 63029-222-09 | Tagamet | 1 in 1 CARTON | TABLET | 1 | 9 | |
| 63029-222-11 | Tagamet | 1 in 1 CARTON | TABLET | 1 | 9 | |
| 63029-222-11 | Tagamet | 100 in 1 BOTTLE | TABLET | 100 | 9 | |
| 63029-222-12 | Tagamet | 6 in 1 BLISTER PACK | TABLET | 6 | 9 | |
| 63029-222-12 | Tagamet | 2 in 1 BOX | TABLET | 2 | 9 | |
| 63029-222-70 | Tagamet | 1 in 1 CARTON | TABLET | 1 | 9 | |
| 63029-222-70 | Tagamet | 70 in 1 BOTTLE | TABLET | 70 | 9 | |
| 63029-223-30 | Tagamet | 10 in 1 BLISTER PACK | TABLET | 10 | 9 | |
| 63029-223-30 | Tagamet | 3 in 1 BOX | TABLET | 3 | 9 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63029-222 | TAGAMET (CIMETIDINE) TABLET [MEDTECH PRODUCTS INC.] | 9 | Current NDC, Legacy NDC, 20 package rows | 20240621_e6401e0a-8612-42e8-bf89-2d67243f28dc.zip |
| 63029-223 | TAGAMET (CIMETIDINE) TABLET [MEDTECH PRODUCTS INC.] | 9 | Current NDC, 2 package rows | 20240621_e6401e0a-8612-42e8-bf89-2d67243f28dc.zip |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63029-222-01 | EA - Each | 63029-222 | 018efaa5-5ae1-4f22-8d25-4f421612d223 | 1 | 2022-06-06 |
| 63029-222-02 | EA - Each | 63029-222 | df825d83-df13-4c32-9244-6540af20c15b | 1 | 2022-06-06 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CIMETIDINE | ACTIVE INGREDIENT | 80061L1WGD | 3 | |
| CIMETIDINE | ACTIVE MOIETY | 80061L1WGD | 3 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | 3 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 3 | |
| POLYETHYLENE GLYCOLS | INACTIVE INGREDIENT | 3WJQ0SDW1A | 3 | |
| POLYSORBATE 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | 3 | |
| POVIDONES | INACTIVE INGREDIENT | FZ989GH94E | 3 | |
| POWDERED CELLULOSE | INACTIVE INGREDIENT | SMD1X3XO9M | 3 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | 3 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | 3 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | 3 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 63029-222 | 63029-222-02, 63029-222-01, 63029-222-03, 63029-222-04, 63029-222-05, 63029-222-70, 63029-222-06, 63029-222-09, 63029-222-11, 63029-222-12 |
| 63029-223 | 63029-223-30 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET / ORAL | 1127 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | TABLET / ORAL | 233 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET / ORAL | 232 mg | ||
| POVIDONES | POVIDONE | FZ989GH94E | TABLET / ORAL | 216 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET / ORAL | 1127 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | TABLET / ORAL | 233 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET / ORAL | 1127 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | TABLET / ORAL | 1582 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | TABLET / ORAL | 233 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | TABLET / ORAL | 233 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | TABLET / ORAL | 1582 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET / ORAL | 232 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET / ORAL | 1127 mg | ||
| POVIDONES | POVIDONE | FZ989GH94E | TABLET / ORAL | 216 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | TABLET / ORAL | 233 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | TABLET / ORAL | 233 mg | ||
| POVIDONES | POVIDONE | FZ989GH94E | TABLET / ORAL | 216 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET / ORAL | 232 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | TABLET / ORAL | 1582 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | TABLET / ORAL | 233 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | TABLET / ORAL | 233 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | TABLET / ORAL | 1582 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET / ORAL | 232 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | TABLET / ORAL | 233 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET / ORAL | 232 mg | ||
| POVIDONES | POVIDONE | FZ989GH94E | TABLET / ORAL | 216 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | TABLET / ORAL | 233 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | TABLET / ORAL | 1582 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET / ORAL | 1127 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET / ORAL | 232 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | TABLET / ORAL | 233 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| POLYSORBATE 80 | POLYSORBATE 80 | 6OZP39ZG8H | TABLET / ORAL | 233 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | TABLET / ORAL | 1582 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| POVIDONES | POVIDONE | FZ989GH94E | TABLET / ORAL | 216 mg | ||
| POVIDONES | POVIDONE | FZ989GH94E | TABLET / ORAL | 216 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | TABLET / ORAL | 1582 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| POWDERED CELLULOSE | POWDERED CELLULOSE | SMD1X3XO9M | TABLET / ORAL | 1582 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | TABLET / ORAL | 233 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET / ORAL | 1127 mg | ||
| POVIDONES | POVIDONE | FZ989GH94E | TABLET / ORAL | 216 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | TABLET / ORAL | 233 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET / ORAL | 232 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| SODIUM LAURYL SULFATE | SODIUM LAURYL SULFATE | 368GB5141J | TABLET / ORAL | 233 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET / ORAL | 232 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET / ORAL | 232 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020238-001 | TAGAMET HB | CIMETIDINE | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1995-06-19 | |
| N020238-002 | TAGAMET HB | CIMETIDINE | 200MG | TABLET / ORAL | RLD, RS | 1996-08-21 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N020238-001 | TAGAMET HB | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1995-06-19 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N020238-002 | TAGAMET HB | 200MG | TABLET / ORAL | RLD, RS | 1996-08-21 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N020238-001 | TAGAMET HB | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1995-06-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N020238-002 | TAGAMET HB | 200MG | TABLET / ORAL | RLD, RS | 1996-08-21 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N020238-001 | TAGAMET HB | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1995-06-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N020238-002 | TAGAMET HB | 200MG | TABLET / ORAL | RLD, RS | 1996-08-21 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020238-001 | TAGAMET HB | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1995-06-19 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020238-002 | TAGAMET HB | 200MG | TABLET / ORAL | RLD, RS | 1996-08-21 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020238-001 | TAGAMET HB | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1995-06-19 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020238-002 | TAGAMET HB | 200MG | TABLET / ORAL | RLD, RS | 1996-08-21 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020238-001 | TAGAMET HB | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1995-06-19 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020238-002 | TAGAMET HB | 200MG | TABLET / ORAL | RLD, RS | 1996-08-21 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020238-001 | TAGAMET HB | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1995-06-19 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020238-002 | TAGAMET HB | 200MG | TABLET / ORAL | RLD, RS | 1996-08-21 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020238-001 | TAGAMET HB | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1995-06-19 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020238-002 | TAGAMET HB | 200MG | TABLET / ORAL | RLD, RS | 1996-08-21 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020238-001 | TAGAMET HB | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1995-06-19 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020238-002 | TAGAMET HB | 200MG | TABLET / ORAL | RLD, RS | 1996-08-21 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020238-001 | TAGAMET HB | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1995-06-19 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020238-002 | TAGAMET HB | 200MG | TABLET / ORAL | RLD, RS | 1996-08-21 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N020238-001 | TAGAMET HB | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1995-06-19 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N020238-002 | TAGAMET HB | 200MG | TABLET / ORAL | RLD, RS | 1996-08-21 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N020238-001 | TAGAMET HB | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1995-06-19 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N020238-002 | TAGAMET HB | 200MG | TABLET / ORAL | RLD, RS | 1996-08-21 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N020238-001 | TAGAMET HB | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1995-06-19 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N020238-002 | TAGAMET HB | 200MG | TABLET / ORAL | RLD, RS | 1996-08-21 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N020238-001 | TAGAMET HB | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1995-06-19 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N020238-002 | TAGAMET HB | 200MG | TABLET / ORAL | RLD, RS | 1996-08-21 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N020238-001 | TAGAMET HB | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1995-06-19 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N020238-002 | TAGAMET HB | 200MG | TABLET / ORAL | RLD, RS | 1996-08-21 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N020238-001 | TAGAMET HB | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1995-06-19 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N020238-002 | TAGAMET HB | 200MG | TABLET / ORAL | RLD, RS | 1996-08-21 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N020238-001 | TAGAMET HB | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1995-06-19 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N020238-002 | TAGAMET HB | 200MG | TABLET / ORAL | RLD, RS | 1996-08-21 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N020238-001 | TAGAMET HB | 100MG | TABLET / ORAL | RLD | 1995-06-19 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N020238-002 | TAGAMET HB | 200MG | TABLET / ORAL | RLD, RS | 1996-08-21 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N020238-001 | TAGAMET HB | 100MG | TABLET / ORAL | RLD | 1995-06-19 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N020238-002 | TAGAMET HB | 200MG | TABLET / ORAL | RLD, RS | 1996-08-21 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N020238-001 | TAGAMET HB | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | TABLET / ORAL | RLD | 1995-06-19 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N020238-002 | TAGAMET HB | 200MG | TABLET / ORAL | RLD, RS | 1996-08-21 | 74a2ff9319b5… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tagamet | CIMETIDINE | Medtech Products Inc. | e6401e0a-8612-42e8-bf89-2d67243f28dc | 2024-06-10 | Warnings | 63029-222-11 63029-222-02 63029-222-70 63029-223-30 63029-222-04 63029-222-09 63029-222-12 63029-222-01 63029-222-03 63029-222-06 63029-222-05 63029-223 63029-222 63029022202 63029022204 63029022212 63029022211 63029022206 63029022270 63029022209 63029022205 63029022330 63029022201 63029022203 e29142a4-59e0-4f6d-8a1f-3050b21491a2 e6401e0a-8612-42e8-bf89-2d67243f28dc |
Adverse event summaries are temporarily unavailable. Other product information remains available.